Skip to main content
TXMD
NASDAQ Life Sciences

TherapeuticsMD Q2 License Revenue Falls; Strategic Review Continues

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$2.07
Mkt Cap
$23.959M
52W Low
$0.99
52W High
$2.95
52W Position info
109% above low
Off High info
30% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

TXMD has more than doubled off its 52-week low of $0.99 on light trading volume (0.4× avg).

Summary

Q2 net income dropped to $164K from $545K a year ago, driven by lower licensed product sales. The company is still evaluating strategic alternatives, including a possible merger or asset sale, with no timeline set. A CAD 500K milestone payment will hit Q3 revenue. With a market cap around $24M and a going-concern warning already disclosed, the revenue decline adds pressure to the strategic review process.

At the time of this announcement, TXMD was trading at $2.07 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $24M. The 52-week trading range was $0.99 to $2.95. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

TXMD - Latest Insights

TXMD
Nov 13, 2026, 4:07 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.87
Real-time Price: $1.81 info
Change: -$0.060 (-3%) info
Market Cap: $20.95M info
TXMD
Aug 11, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.07
Real-time Price: $1.81 info
Change: -$0.260 (-13%) info
Market Cap: $20.95M info
TXMD
Aug 11, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.07
Real-time Price: $1.81 info
Change: -$0.260 (-13%) info
Market Cap: $20.95M info
TXMD
May 12, 2026, 4:16 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.94
Real-time Price: $1.81 info
Change: -$0.130 (-7%) info
Market Cap: $20.95M info
TXMD
May 12, 2026, 4:13 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $1.95
Real-time Price: $1.81 info
Change: -$0.140 (-7%) info
Market Cap: $20.95M info